CA2927319C - Identification d'alleles a haute resolution - Google Patents
Identification d'alleles a haute resolution Download PDFInfo
- Publication number
- CA2927319C CA2927319C CA2927319A CA2927319A CA2927319C CA 2927319 C CA2927319 C CA 2927319C CA 2927319 A CA2927319 A CA 2927319A CA 2927319 A CA2927319 A CA 2927319A CA 2927319 C CA2927319 C CA 2927319C
- Authority
- CA
- Canada
- Prior art keywords
- alleles
- map
- hla
- sequencing reads
- locus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/20—Sequence assembly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La présente invention concerne des procédés de détermination précise des allèles présents au niveau d'un locus qui est largement applicable à n'importe quel locus, comprenant des loci hautement polymorphiques, tels que des loci HLA, des loci BGA et des loci HV. Des modes de réalisation des procédés de l'invention sont utiles dans une large gamme d'applications, comprenant, par exemple, la greffe d'organe, les médicaments personnalisés, les diagnostics, les sciences judiciaires et l'anthropologie.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361891193P | 2013-10-15 | 2013-10-15 | |
US61/891,193 | 2013-10-15 | ||
PCT/IB2014/002843 WO2015056103A2 (fr) | 2013-10-15 | 2014-10-14 | Identification d'allèles à haute résolution |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2927319A1 CA2927319A1 (fr) | 2015-04-23 |
CA2927319C true CA2927319C (fr) | 2023-03-28 |
Family
ID=52630401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2927319A Active CA2927319C (fr) | 2013-10-15 | 2014-10-14 | Identification d'alleles a haute resolution |
Country Status (8)
Country | Link |
---|---|
US (2) | US10162933B2 (fr) |
EP (1) | EP3058095B1 (fr) |
JP (2) | JP6491651B2 (fr) |
KR (1) | KR102386134B1 (fr) |
CN (1) | CN106103736B (fr) |
AU (1) | AU2014335877B2 (fr) |
CA (1) | CA2927319C (fr) |
WO (1) | WO2015056103A2 (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9116866B2 (en) | 2013-08-21 | 2015-08-25 | Seven Bridges Genomics Inc. | Methods and systems for detecting sequence variants |
US9898575B2 (en) | 2013-08-21 | 2018-02-20 | Seven Bridges Genomics Inc. | Methods and systems for aligning sequences |
EP3058095B1 (fr) | 2013-10-15 | 2019-12-25 | Regeneron Pharmaceuticals, Inc. | Identification d'allèles à haute résolution |
EP3058093B1 (fr) | 2013-10-18 | 2019-07-17 | Seven Bridges Genomics Inc. | Méthodes et systèmes d'identification de mutations induites par une maladie |
KR20160062763A (ko) | 2013-10-18 | 2016-06-02 | 세븐 브릿지스 지노믹스 인크. | 유전자 샘플을 유전자형 결정하기 위한 방법 및 시스템 |
US10832797B2 (en) | 2013-10-18 | 2020-11-10 | Seven Bridges Genomics Inc. | Method and system for quantifying sequence alignment |
US11049587B2 (en) | 2013-10-18 | 2021-06-29 | Seven Bridges Genomics Inc. | Methods and systems for aligning sequences in the presence of repeating elements |
US9092402B2 (en) | 2013-10-21 | 2015-07-28 | Seven Bridges Genomics Inc. | Systems and methods for using paired-end data in directed acyclic structure |
WO2015085350A1 (fr) * | 2013-12-10 | 2015-06-18 | Conexio Genomics Pty Ltd | Procédés et sondes pour identifier des allèles géniques |
WO2015105963A1 (fr) | 2014-01-10 | 2015-07-16 | Seven Bridges Genomics Inc. | Systèmes et procédés d'utilisation d'allèles connus en cartographie de lectures |
US9817944B2 (en) | 2014-02-11 | 2017-11-14 | Seven Bridges Genomics Inc. | Systems and methods for analyzing sequence data |
WO2016141294A1 (fr) | 2015-03-05 | 2016-09-09 | Seven Bridges Genomics Inc. | Systèmes et procédés d'analyse de motifs génomiques |
US10793895B2 (en) | 2015-08-24 | 2020-10-06 | Seven Bridges Genomics Inc. | Systems and methods for epigenetic analysis |
MX2018002293A (es) | 2015-08-25 | 2018-09-05 | Nantomics Llc | Sistemas y métodos para las llamadas variantes de alta precisión. |
US10724110B2 (en) | 2015-09-01 | 2020-07-28 | Seven Bridges Genomics Inc. | Systems and methods for analyzing viral nucleic acids |
US10584380B2 (en) | 2015-09-01 | 2020-03-10 | Seven Bridges Genomics Inc. | Systems and methods for mitochondrial analysis |
WO2017058904A1 (fr) * | 2015-09-28 | 2017-04-06 | Sirona Genomics, Inc. | Base de données et procédé de déséquilibre de liaison |
US11347704B2 (en) | 2015-10-16 | 2022-05-31 | Seven Bridges Genomics Inc. | Biological graph or sequence serialization |
KR101651817B1 (ko) | 2015-10-28 | 2016-08-29 | 대한민국 | Ngs 라이브러리 제작용 프라이머 세트 및 이를 이용한 ngs 라이브러리 제작방법 및 키트 |
US20170199960A1 (en) | 2016-01-07 | 2017-07-13 | Seven Bridges Genomics Inc. | Systems and methods for adaptive local alignment for graph genomes |
US10364468B2 (en) | 2016-01-13 | 2019-07-30 | Seven Bridges Genomics Inc. | Systems and methods for analyzing circulating tumor DNA |
US10262102B2 (en) | 2016-02-24 | 2019-04-16 | Seven Bridges Genomics Inc. | Systems and methods for genotyping with graph reference |
US10790044B2 (en) | 2016-05-19 | 2020-09-29 | Seven Bridges Genomics Inc. | Systems and methods for sequence encoding, storage, and compression |
CA3022851A1 (fr) * | 2016-05-27 | 2017-11-30 | Human Longevity, Inc. | Methodes de typage de l'antigene leucocytaire humain |
WO2017218864A1 (fr) * | 2016-06-17 | 2017-12-21 | Mayo Foundation For Medical Education And Research | Procédés et matériaux pour l'utilisation efficace de l'enrichissement ciblé combiné de régions génomiques et du séquençage de génome entier à faible chevauchement |
KR101815529B1 (ko) * | 2016-07-29 | 2018-01-30 | (주)신테카바이오 | 휴먼 하플로타이핑 시스템 및 방법 |
US11289177B2 (en) | 2016-08-08 | 2022-03-29 | Seven Bridges Genomics, Inc. | Computer method and system of identifying genomic mutations using graph-based local assembly |
US11250931B2 (en) | 2016-09-01 | 2022-02-15 | Seven Bridges Genomics Inc. | Systems and methods for detecting recombination |
US11324801B2 (en) | 2016-09-02 | 2022-05-10 | University Of Utah Research Foundation | NNIF and nNIF-related peptides and related methods |
EP3516057A4 (fr) * | 2016-09-26 | 2020-06-03 | Sirona Genomics, Inc. | Procédé de génotypage d'antigène leucocytaire humain et détermination de la diversité d'haplotype de hla dans une population d'échantillons |
US10319465B2 (en) | 2016-11-16 | 2019-06-11 | Seven Bridges Genomics Inc. | Systems and methods for aligning sequences to graph references |
KR101936933B1 (ko) * | 2016-11-29 | 2019-01-09 | 연세대학교 산학협력단 | 염기서열의 변이 검출방법 및 이를 이용한 염기서열의 변이 검출 디바이스 |
US20210265010A1 (en) * | 2016-12-15 | 2021-08-26 | Sirona Genomics, Inc. | Genotyping diploid samples with coverage plot of unexplained reads |
US11347844B2 (en) | 2017-03-01 | 2022-05-31 | Seven Bridges Genomics, Inc. | Data security in bioinformatic sequence analysis |
US10726110B2 (en) | 2017-03-01 | 2020-07-28 | Seven Bridges Genomics, Inc. | Watermarking for data security in bioinformatic sequence analysis |
CA3068203A1 (fr) | 2017-07-14 | 2019-01-17 | The Francis Crick Institute Limited | Analyse d'alleles hla dans des tumeurs et utilisations associees |
KR102035615B1 (ko) * | 2017-08-07 | 2019-10-23 | 연세대학교 산학협력단 | 유전자 패널에 기초한 염기서열의 변이 검출방법 및 이를 이용한 염기서열의 변이 검출 디바이스 |
WO2019050958A2 (fr) * | 2017-09-06 | 2019-03-14 | Nant Holdings Ip, Llc | Correspondance de tissu hla et procédés associés |
US12046325B2 (en) | 2018-02-14 | 2024-07-23 | Seven Bridges Genomics Inc. | System and method for sequence identification in reassembly variant calling |
US11819520B2 (en) | 2018-02-23 | 2023-11-21 | Duke University | Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants |
EP3755346A4 (fr) * | 2018-02-23 | 2022-03-09 | Duke University & Medical Center | Greffe de tissus de thymus cultivés favorisant une tolérance spécifique au donneur à des greffons d'organes solides allogéniques |
CN109448789A (zh) * | 2018-09-17 | 2019-03-08 | 上海派森诺生物科技股份有限公司 | 一种基于perl语言的种群特异SNP位点的自动化分析方法 |
CN110942806A (zh) * | 2018-09-25 | 2020-03-31 | 深圳华大法医科技有限公司 | 一种血型基因分型方法和装置及存储介质 |
JP2022534071A (ja) * | 2019-05-22 | 2022-07-27 | ソウル ナショナル ユニバーシティ アールアンドディービー ファウンデーション | Ngsデータを用いて遺伝型を予測する方法及び装置 |
CN111312332B (zh) * | 2020-02-13 | 2020-10-30 | 国家卫生健康委科学技术研究所 | 基于hla基因的生物信息处理方法、装置及终端 |
WO2023196925A2 (fr) * | 2022-04-07 | 2023-10-12 | Guardant Health, Inc. | Méthodes et systèmes de typage d'allèles |
WO2023225607A2 (fr) * | 2022-05-18 | 2023-11-23 | The University Of North Carolina At Chapel Hill | Génotypage de hla amélioré par identifiant moléculaire unique et quantification de transcription à l'aide d'une technologie à nanopores |
WO2024112946A1 (fr) * | 2022-11-22 | 2024-05-30 | University Of Southern California | Test de méthylation de l'adn acellulaire pour le cancer du sein |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100256917A1 (en) * | 2007-06-15 | 2010-10-07 | Mcvean Gilean | Allelic determination |
CN104160391A (zh) * | 2011-09-16 | 2014-11-19 | 考利达基因组股份有限公司 | 确定异质样本的基因组中的变异 |
EP3058095B1 (fr) | 2013-10-15 | 2019-12-25 | Regeneron Pharmaceuticals, Inc. | Identification d'allèles à haute résolution |
-
2014
- 2014-10-14 EP EP14843178.6A patent/EP3058095B1/fr active Active
- 2014-10-14 CA CA2927319A patent/CA2927319C/fr active Active
- 2014-10-14 WO PCT/IB2014/002843 patent/WO2015056103A2/fr active Application Filing
- 2014-10-14 US US14/513,952 patent/US10162933B2/en active Active
- 2014-10-14 CN CN201480066695.1A patent/CN106103736B/zh active Active
- 2014-10-14 JP JP2016523227A patent/JP6491651B2/ja active Active
- 2014-10-14 KR KR1020167012427A patent/KR102386134B1/ko active IP Right Grant
- 2014-10-14 AU AU2014335877A patent/AU2014335877B2/en active Active
-
2018
- 2018-10-19 US US16/165,510 patent/US11594302B2/en active Active
-
2019
- 2019-03-01 JP JP2019037501A patent/JP6715977B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
US10162933B2 (en) | 2018-12-25 |
AU2014335877A2 (en) | 2016-06-16 |
US20150110754A1 (en) | 2015-04-23 |
WO2015056103A3 (fr) | 2016-01-21 |
US11594302B2 (en) | 2023-02-28 |
AU2014335877A1 (en) | 2016-05-05 |
CN106103736A (zh) | 2016-11-09 |
JP2019145114A (ja) | 2019-08-29 |
WO2015056103A2 (fr) | 2015-04-23 |
AU2014335877B2 (en) | 2020-09-17 |
JP2016541043A (ja) | 2016-12-28 |
CN106103736B (zh) | 2020-03-03 |
US20190121940A1 (en) | 2019-04-25 |
KR20160063400A (ko) | 2016-06-03 |
EP3058095A2 (fr) | 2016-08-24 |
JP6491651B2 (ja) | 2019-03-27 |
KR102386134B1 (ko) | 2022-04-12 |
EP3058095B1 (fr) | 2019-12-25 |
JP6715977B2 (ja) | 2020-07-01 |
CA2927319A1 (fr) | 2015-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11594302B2 (en) | High resolution allele identification | |
Bai et al. | Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads | |
Levin et al. | Association of HLA-DRB1 with sarcoidosis susceptibility and progression in African Americans | |
JP6308724B2 (ja) | Hla遺伝子のマルチプレックスdnaタイピング方法及びキット | |
Hoffman et al. | Rare complement factor H variant associated with age-related macular degeneration in the Amish | |
AU2016293025A1 (en) | System and methodology for the analysis of genomic data obtained from a subject | |
WO2014065410A1 (fr) | Procédé et trousse pour le typage d'adn de gène hla | |
Freudenburg-de Graaf et al. | Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands | |
Chelysheva et al. | RNA2HLA: HLA-based quality control of RNA-seq datasets | |
CN103074444A (zh) | 组织相容性抗原决定簇基因高通量测序的hla基因分型方法 | |
US20220088174A1 (en) | Genomic variants in ig gene regions and uses of same | |
Lázaro-Guevara et al. | Identification of RP1 as the genetic cause of retinitis pigmentosa in a multi-generational pedigree using Extremely Low-Coverage Whole Genome Sequencing (XLC-WGS) | |
Pineda et al. | Corrigendum: Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant. | |
Olm | Strain-resolved metagenomic analysis of the premature infant microbiome and other natural microbial communities | |
US20240294984A1 (en) | Methods and systems for allele typing | |
JP2018201492A (ja) | モモアレルギーの発症のしやすさを判定する方法 | |
JP2018201493A (ja) | エビアレルギーの発症のしやすさを判定する方法 | |
Pyo et al. | Genotyping of canine MHC gene DLA‐88 by next‐generation sequencing reveals high frequencies of new allele discovery and gene duplication | |
이선호 | New Methods for SNV/InDel Calling and Haplotyping from Next Generation Sequencing Data | |
Claeys | Benchmark of NGS-based prediction algorithms for | |
Quinones-Valdez et al. | Long-read RNA-seq demarcates cis-and trans-directed alternative RNA splicing | |
Simonti | Leveraging Biobanks and PheWAS to Uncover the Health Consequences of Recent Human Evolution | |
Pineda Sanjuan et al. | Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant | |
WO2024209074A1 (fr) | Procédé pour le calcul du score relatif au risque de pronostic défavorable dans les infections par des maladies virales respiratoires, par l'utilisation de la génomique de l'hôte | |
AU2023249775A1 (en) | Methods and systems for allele typing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20190911 |
|
EEER | Examination request |
Effective date: 20190911 |
|
EEER | Examination request |
Effective date: 20190911 |
|
EEER | Examination request |
Effective date: 20190911 |